These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 830744)

  • 1. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.
    Bernstein ID; Wright PW; Cohen E
    J Immunol; 1976 May; 116(5):1367-72. PubMed ID: 58029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity.
    Glaser M; Lavrin DH; Herberman RB
    J Immunol; 1976 Jun; 116(6):1507-11. PubMed ID: 58036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
    Glaser M; Bonnard GD; Herberman RB
    J Immunol; 1976 Feb; 116(2):430-6. PubMed ID: 1082456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of cellular proliferation and the generation of cytotoxic cells in an in vitro secondary immune response to syngeneic rat lymphoma cells.
    Bernstein ID; Cohen EF; Wright PW
    J Immunol; 1977 Mar; 118(3):1090-4. PubMed ID: 845434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin.
    Glaser M; Djeu JY; Kirchner H; Herberman RB
    J Immunol; 1976 Jun; 116(6):1512-9. PubMed ID: 774985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.
    Srinivasa Rao V; Bonavida B
    Cancer Res; 1977 Sep; 37(9):3385-9. PubMed ID: 884683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific tumor immunity induced with mitomycin C-treated syngeneic tumor cells (MCT). Effects of carrageenan and trypan blue on MCT-induced immunity in mice.
    Wu RL; Kearney R
    J Natl Cancer Inst; 1980 Jan; 64(1):81-7. PubMed ID: 6928050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations.
    Oehler JR; Herberman RB
    J Natl Cancer Inst; 1979 Mar; 62(3):525-9. PubMed ID: 153984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.
    Yoshizawa H; Chang AE; Shu S
    J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the in vitro secondary response to syngeneic tumor and of in vivo tumor therapy with immune cells by culture-induced suppressor cells.
    Greenberg PD; Cheever M; Fefer A
    J Immunol; 1979 Aug; 123(2):515-22. PubMed ID: 222839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
    Shu SY; Chou T; Sakai K
    J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
    Shu S; Rosenberg SA
    J Immunol; 1985 Oct; 135(4):2895-903. PubMed ID: 2411817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy in proliferative and cytotoxic responses of WF rats to syngeneic Gross virus-induced lymphoma cells in vitro.
    Wright PW; Loop SM; Bernstein ID
    J Natl Cancer Inst; 1980 Feb; 64(2):303-8. PubMed ID: 6965510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.